Jaguar Health (JAGX) Finished Goods (2018 - 2026)

Jaguar Health (JAGX) has 9 years of Finished Goods data on file, last reported at $856000.0 in Q1 2026.

• On a quarterly basis, Finished Goods fell 9.8% year-over-year to $856000.0 in Q1 2026; TTM through Mar 2026 was $856000.0, a 9.8% decrease from a year earlier, with the FY2025 full-year figure at $1.3 million, up 21.51% from the prior year.
• Finished Goods for Q1 2026 stood at $856000.0, down from $1.3 million in the prior quarter.
• Over the last five years, Finished Goods for JAGX reached as high as $1.7 million in Q2 2022 and fell as low as $615000.0 in Q4 2023.
• Historically, Finished Goods has averaged $1.0 million across 5 years, with a median of $949000.0 in 2025.
• Across the five-year window, Finished Goods sank 53.55% in 2023 and jumped 76.91% in 2024, its largest moves.
• Year by year, Finished Goods stood at $1.3 million in 2022, then sank by 53.55% to $615000.0 in 2023, then soared by 76.91% to $1.1 million in 2024, then grew by 21.51% to $1.3 million in 2025, then sank by 35.25% to $856000.0 in 2026.
• Per Business Quant data, the three most recent Finished Goods figures were $856000.0 in Q1 2026, $1.3 million in Q4 2025, and $1.2 million in Q3 2025.